Acquired Coagulation Factor V Inhibitor That Was Successfully Treated with Oral Corticosteroid Therapy

Intern Med. 2021 Aug 15;60(16):2663-2666. doi: 10.2169/internalmedicine.7453-21. Epub 2021 Jun 12.

Abstract

Acquired coagulation factor V (FV) inhibitors are rare disorders in which antibodies against FV develop under various conditions. We herein report the case of a 71-year-old woman with FV inhibitor during radiochemotherapy for pancreatic cancer. Multiple purpuras suddenly appeared on her bilateral upper limbs with prolonged coagulation data (APTT 97.3 seconds). The FV activity was less than 3% and the FV inhibitor was positive (1.7 B.U./mL). Oral prednisolone induced a rapid normalization of the coagulation data and FV activity and a rapid disappearance of FV inhibitor within 7 days. Early diagnosis and treatment may therefore be important in cases of FV inhibitor.

Keywords: corticosteroids; factor V inhibitor; pancreatic cancer.

Publication types

  • Case Reports

MeSH terms

  • Adrenal Cortex Hormones
  • Aged
  • Blood Coagulation
  • Blood Coagulation Factor Inhibitors*
  • Blood Coagulation Tests
  • Factor V*
  • Female
  • Humans

Substances

  • Adrenal Cortex Hormones
  • Blood Coagulation Factor Inhibitors
  • Factor V